Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Gebhart, Dana
Williams, Steven R.
Bishop-Lilly, Kimberly A.
Govoni, Gregory R.
Willner, Kristin M.
Butani, Amy
Sozhamannan, Shanmuga
Martin, David
Fortier, Louis-Charles
and
Scholl, Dean
2012.
Novel High-Molecular-Weight, R-Type Bacteriocins of Clostridium difficile.
Journal of Bacteriology,
Vol. 194,
Issue. 22,
p.
6240.
Lessa, F. C.
Gould, C. V.
and
McDonald, L. C.
2012.
Current Status of Clostridium difficile Infection Epidemiology.
Clinical Infectious Diseases,
Vol. 55,
Issue. suppl 2,
p.
S65.
Khanna, Sahil
Pardi, Darrell S.
Rosenblatt, Jon E.
Patel, Robin
Kammer, Patricia P.
and
Baddour, Larry M.
2012.
An Evaluation of Repeat Stool Testing for Clostridium difficile Infection by Polymerase Chain Reaction.
Journal of Clinical Gastroenterology,
Vol. 46,
Issue. 10,
p.
846.
Crawford, Tonya
Huesgen, Emily
and
Danziger, Larry
2012.
Fidaxomicin: A novel macrocyclic antibiotic for the treatment of Clostridium difficile infection.
American Journal of Health-System Pharmacy,
Vol. 69,
Issue. 11,
p.
933.
Madan, Rajat
and
Jr, William A. Petri
2012.
Immune responses to Clostridium difficile infection.
Trends in Molecular Medicine,
Vol. 18,
Issue. 11,
p.
658.
Kang, JaHyun
Sickbert-Bennett, Emily E.
Brown, Vickie M.
Weber, David J.
and
Rutala, William A.
2012.
Relative frequency of health care-associated pathogens by infection site at a university hospital from 1980 to 2008.
American Journal of Infection Control,
Vol. 40,
Issue. 5,
p.
416.
Meyer, E.
Gastmeier, P.
Weizel-Kage, D.
and
Schwab, F.
2012.
Associations between nosocomial meticillin-resistant Staphylococcus aureus and nosocomial Clostridium difficile-associated diarrhoea in 89 German hospitals.
Journal of Hospital Infection,
Vol. 82,
Issue. 3,
p.
181.
Liao, Chun-Hsing
Ko, Wen-Chien
Lu, Jang-Jih
and
Hsueh, Po-Ren
2012.
Characterizations of Clinical Isolates of Clostridium difficile by Toxin Genotypes and by Susceptibility to 12 Antimicrobial Agents, Including Fidaxomicin (OPT-80) and Rifaximin: a Multicenter Study in Taiwan.
Antimicrobial Agents and Chemotherapy,
Vol. 56,
Issue. 7,
p.
3943.
Stein, Benjamin E.
Greenough, William B.
and
Mears, Simon C.
2012.
Management and Prevention of Recurrent Clostridium Difficile Infection in Patients After Total Joint Arthroplasty.
Geriatric Orthopaedic Surgery & Rehabilitation,
Vol. 3,
Issue. 4,
p.
157.
McCollum, David L.
and
Rodriguez, J. Martin
2012.
Detection, Treatment, and Prevention of Clostridium difficile Infection.
Clinical Gastroenterology and Hepatology,
Vol. 10,
Issue. 6,
p.
581.
Chen, Luke F
and
Anderson, Deverick J
2012.
Efficacy and safety of fidaxomicin compared with oral vancomycin for the treatment of adults with Clostridium difficile-associated diarrhea: data from the OPT-80-003 and OPT-80-004 studies.
Future Microbiology,
Vol. 7,
Issue. 6,
p.
677.
Shin, Bo-Moon
Mun, Se Jin
Yoo, Soo Jin
and
Kuak, Eun Young
2012.
Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR Assays Using Toxigenic Clostridium difficile Culture for Direct Detection of
tcdB
from Stool Specimens
.
Journal of Clinical Microbiology,
Vol. 50,
Issue. 11,
p.
3765.
Petrella, Laurica A.
Sambol, Susan P.
Cheknis, Adam
Nagaro, Kristin
Kean, Yin
Sears, Pamela S.
Babakhani, Farah
Johnson, Stuart
and
Gerding, Dale N.
2012.
Decreased Cure and Increased Recurrence Rates for Clostridium difficile Infection Caused by the Epidemic C. difficile BI Strain.
Clinical Infectious Diseases,
Vol. 55,
Issue. 3,
p.
351.
Cecil, Jane A.
2012.
Clostridium difficile: Changing Epidemiology, Treatment and Infection Prevention Measures.
Current Infectious Disease Reports,
Vol. 14,
Issue. 6,
p.
612.
Rutala, William A.
Gergen, Maria F.
and
Weber, David J.
2012.
Efficacy of Different Cleaning and Disinfection Methods against Clostridium difficile Spores: Importance of Physical Removal versus Sporicidal Inactivation.
Infection Control & Hospital Epidemiology,
Vol. 33,
Issue. 12,
p.
1255.
Lessa, Fernanda C.
2013.
Community-associated Clostridium difficile infection: How real is it?.
Anaerobe,
Vol. 24,
Issue. ,
p.
121.
DePestel, Daryl D.
and
Aronoff, David M.
2013.
Epidemiology of Clostridium difficile Infection.
Journal of Pharmacy Practice,
Vol. 26,
Issue. 5,
p.
464.
Fayerberg, Eugene
Bouchard, Jacques
and
Kellie, Susan M.
2013.
Knowledge, attitudes and practice regarding Clostridium difficile: A survey of physicians in an academic medical center.
American Journal of Infection Control,
Vol. 41,
Issue. 3,
p.
266.
Arora, Vaneet
Shah, Dhara
and
Garey, Kevin
2013.
Overview ofClostridium difficileInfection as an Emerging Health Care Facility–Acquired Infection.
Hospital Pharmacy,
Vol. 48,
Issue. Supplement 1,
p.
S1.
Moehring, Rebekah W.
Lofgren, Eric T.
and
Anderson, Deverick J.
2013.
Impact of Change to Molecular Testing for Clostridium difficile Infection on Healthcare Facility–Associated Incidence Rates.
Infection Control & Hospital Epidemiology,
Vol. 34,
Issue. 10,
p.
1055.